Non-Hodgkin Lymphoma (NHL)

Overview of NHL.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyOncology

Clinical Guidelines

ESMO Clinical Practice Guideline: Diffuse Large B Cell Lymphoma
National
EUROPEAN STANDARD CLINICAL PRACTICE RECOMMENDATIONS FOR NON-HODGKIN LYMPHOMA OF CHILDHOOD
National
National Non-Hodgkin Lymphoma Audit State of the Nation Report
National
NICE guideline [NG52]
National
NICE guideline [NG52]: Non-Hodgkin's lymphoma: diagnosis and management
National
2022 Chinese expert consensus and guidelines on clinical management of cytokine release syndrome in non-Hodgkin's lymphoma
Local
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapy in Non-Hodgkin Lymphoma
Local
Australasian Lymphoma Alliance Consensus Practice Statements: Lymphoma bendamustine and rituximab
Local
Childhood Non-Hodgkin Lymphoma Treatment (PDQ®) – Health Professional Version
Local
Clinical Practice Recommendations for Hematopoietic Cell Transplantation in Follicular Lymphoma
Local
ESMO Clinical Practice Guidelines: Marginal zone lymphomas
Local
EUROPEAN STANDARD CLINICAL PRACTICE RECOMMENDATIONS FOR NON-HODGKIN LYMPHOMA OF CHILDHOOD
Local
Indolent B-Cell Non-Hodgkin Lymphoma Treatment (PDQ®) – Health Professional Version
Local
NCCN Clinical Practice Guidelines in Oncology: B-Cell Lymphomas. Version 6.2023
Local
Non-Hodgkin Lymphoma Treatment (PDQ®) – Health Professional Version
Local